They are called “mAbs,” short for monoclonal antibodies, and they are a big deal in oncology. One of the immune systems most elegant soldiers, mAbs are formed by B cells, a type of white blood cell produced in the spleen, in response to specific foreign invaders (real and perceived) known…...
A Rapidly Emerging Field of Cancer Treatment
The human body normally runs like a well-oiled machine. It is able to activate muscles and run repairs without a conscious thought. One of the truly fascinating components of the human body is the immune system. The immune system is able to identify potentially harmful foreign matter and destroy it.…...
Novel CAR-T Treatment Approved for Second Indication
In the past two months, the FDA has approved a revolutionary new form of immunotherapy, called chimeric antigen receptor (CAR) T cell therapy, for two blood cancers: B cell acute lymphoblastic leukemia (ALL) in August, 2017 and now on October 18th, for aggressive diffuse large B cell lymphoma (DLBCL), a…...









